Global Radioactive Monoclonal Antibody Sales Market Report 2016

Global Radioactive Monoclonal Antibody Sales Market Report 2016

1 Radioactive Monoclonal Antibody Overview

1.1 Product Overview and Scope of Radioactive Monoclonal Antibody

1.2 Classification of Radioactive Monoclonal Antibody

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Radioactive Monoclonal Antibody

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Radioactive Monoclonal Antibody Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Radioactive Monoclonal Antibody (2011-2021)

1.5.1 Global Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2021)

1.5.2 Global Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

2 Global Radioactive Monoclonal Antibody Competition by Manufacturers, Type and Application

2.1 Global Radioactive Monoclonal Antibody Market Competition by Manufacturers

2.1.1 Global Radioactive Monoclonal Antibody Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Radioactive Monoclonal Antibody Revenue and Share by Manufacturers (2011-2016)

2.2 Global Radioactive Monoclonal Antibody (Volume and Value) by Type

2.2.1 Global Radioactive Monoclonal Antibody Sales and Market Share by Type (2011-2016)

2.2.2 Global Radioactive Monoclonal Antibody Revenue and Market Share by Type (2011-2016)

2.3 Global Radioactive Monoclonal Antibody (Volume and Value) by Regions

2.3.1 Global Radioactive Monoclonal Antibody Sales and Market Share by Regions (2011-2016)

2.3.2 Global Radioactive Monoclonal Antibody Revenue and Market Share by Regions (2011-2016)

2.4 Global Radioactive Monoclonal Antibody (Volume) by Application

3 USA Radioactive Monoclonal Antibody (Volume, Value and Sales Price)

3.1 USA Radioactive Monoclonal Antibody Sales and Value (2011-2016)

3.1.1 USA Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

3.1.2 USA Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

3.1.3 USA Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

3.2 USA Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers

3.3 USA Radioactive Monoclonal Antibody Sales and Market Share by Type

3.4 USA Radioactive Monoclonal Antibody Sales and Market Share by Application

4 China Radioactive Monoclonal Antibody (Volume, Value and Sales Price)

4.1 China Radioactive Monoclonal Antibody Sales and Value (2011-2016)

4.1.1 China Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

4.1.2 China Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

4.1.3 China Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

4.2 China Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers

4.3 China Radioactive Monoclonal Antibody Sales and Market Share by Type

4.4 China Radioactive Monoclonal Antibody Sales and Market Share by Application

5 Europe Radioactive Monoclonal Antibody (Volume, Value and Sales Price)

5.1 Europe Radioactive Monoclonal Antibody Sales and Value (2011-2016)

5.1.1 Europe Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

5.1.2 Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

5.1.3 Europe Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

5.2 Europe Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers

5.3 Europe Radioactive Monoclonal Antibody Sales and Market Share by Type

5.4 Europe Radioactive Monoclonal Antibody Sales and Market Share by Application

6 Japan Radioactive Monoclonal Antibody (Volume, Value and Sales Price)

6.1 Japan Radioactive Monoclonal Antibody Sales and Value (2011-2016)

6.1.1 Japan Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

6.1.2 Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

6.1.3 Japan Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

6.2 Japan Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers

6.3 Japan Radioactive Monoclonal Antibody Sales and Market Share by Type

6.4 Japan Radioactive Monoclonal Antibody Sales and Market Share by Application

7 India Radioactive Monoclonal Antibody (Volume, Value and Sales Price)

7.1 India Radioactive Monoclonal Antibody Sales and Value (2011-2016)

7.1.1 India Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

7.1.2 India Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

7.1.3 India Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

7.2 India Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers

7.3 India Radioactive Monoclonal Antibody Sales and Market Share by Type

7.4 India Radioactive Monoclonal Antibody Sales and Market Share by Application

8 Southeast Asia Radioactive Monoclonal Antibody (Volume, Value and Sales Price)

8.1 Southeast Asia Radioactive Monoclonal Antibody Sales and Value (2011-2016)

8.1.1 Southeast Asia Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

8.2 Southeast Asia Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers

8.3 Southeast Asia Radioactive Monoclonal Antibody Sales and Market Share by Type

8.4 Southeast Asia Radioactive Monoclonal Antibody Sales and Market Share by Application

9 Global Radioactive Monoclonal Antibody Manufacturers Analysis

9.1 Pfizer Inc. (USA)

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Radioactive Monoclonal Antibody Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Abbott Laboratories (USA)

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 122 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Abbott Laboratories (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Genentech Inc. (USA)

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 147 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Genentech Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 GlaxoSmithKline Plc (UK)

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Immunomedics, Inc. (USA)

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Indevus Pharmaceuticals Inc. (USA)

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Novartis AG (Switzerland)

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Novartis AG (Switzerland) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 OSI Pharmaceuticals, Inc. (USA)

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Paladin Labs Inc. (Canada)

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 ALZA Corporation (USA)

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 ALZA Corporation (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Amgen Inc. (USA)

9.12 AstraZeneca PLC (UK)

9.13 Medimmune, LLC (USA)

9.14 Bristol-Myers Squibb Company (USA)

9.15 Cell Genesys Inc. (USA)

9.16 Dendreon Corporation (USA)

9.17 EUSA Pharma, (USA) Inc. (USA)

9.18 F. Hoffmann-La Roche Ltd. (Switzerland)

9.19 Progenics Pharmaceuticals, Inc. (USA)

9.20 Sanofi-Aventis SA (France)

9.21 Spectrum Pharmaceuticals, Inc. (USA)

9.22 Takeda Pharmaceutical Company Limited (Japan)

10 Radioactive Monoclonal Antibody Maufacturing Cost Analysis

10.1 Radioactive Monoclonal Antibody Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Radioactive Monoclonal Antibody

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Radioactive Monoclonal Antibody Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Radioactive Monoclonal Antibody Market Forecast (2016-2021)

14.1 Global Radioactive Monoclonal Antibody Sales, Revenue Forecast (2016-2021)

14.2 Global Radioactive Monoclonal Antibody Sales Forecast by Regions (2016-2021)

14.3 Global Radioactive Monoclonal Antibody Sales Forecast by Type (2016-2021)

14.4 Global Radioactive Monoclonal Antibody Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Radioactive Monoclonal Antibody

Table Classification of Radioactive Monoclonal Antibody

Figure Global Sales Market Share of Radioactive Monoclonal Antibody by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Radioactive Monoclonal Antibody

Figure Global Sales Market Share of Radioactive Monoclonal Antibody by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Figure China Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Figure Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Figure Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Figure India Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Figure Global Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2021)

Figure Global Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2021)

Table Global Radioactive Monoclonal Antibody Sales of Key Manufacturers (2011-2016)

Table Global Radioactive Monoclonal Antibody Sales Share by Manufacturers (2011-2016)

Figure 2015 Radioactive Monoclonal Antibody Sales Share by Manufacturers

Figure 2016 Radioactive Monoclonal Antibody Sales Share by Manufacturers

Table Global Radioactive Monoclonal Antibody Revenue by Manufacturers (2011-2016)

Table Global Radioactive Monoclonal Antibody Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Radioactive Monoclonal Antibody Revenue Share by Manufacturers

Table 2016 Global Radioactive Monoclonal Antibody Revenue Share by Manufacturers

Table Global Radioactive Monoclonal Antibody Sales and Market Share by Type (2011-2016)

Table Global Radioactive Monoclonal Antibody Sales Share by Type (2011-2016)

Figure Sales Market Share of Radioactive Monoclonal Antibody by Type (2011-2016)

Figure Global Radioactive Monoclonal Antibody Sales Growth Rate by Type (2011-2016)

Table Global Radioactive Monoclonal Antibody Revenue and Market Share by Type (2011-2016)

Table Global Radioactive Monoclonal Antibody Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Radioactive Monoclonal Antibody by Type (2011-2016)

Figure Global Radioactive Monoclonal Antibody Revenue Growth Rate by Type (2011-2016)

Table Global Radioactive Monoclonal Antibody Sales and Market Share by Regions (2011-2016)

Table Global Radioactive Monoclonal Antibody Sales Share by Regions (2011-2016)

Figure Sales Market Share of Radioactive Monoclonal Antibody by Regions (2011-2016)

Figure Global Radioactive Monoclonal Antibody Sales Growth Rate by Regions (2011-2016)

Table Global Radioactive Monoclonal Antibody Revenue and Market Share by Regions (2011-2016)

Table Global Radioactive Monoclonal Antibody Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Radioactive Monoclonal Antibody by Regions (2011-2016)

Figure Global Radioactive Monoclonal Antibody Revenue Growth Rate by Regions (2011-2016)

Table Global Radioactive Monoclonal Antibody Sales and Market Share by Application (2011-2016)

Table Global Radioactive Monoclonal Antibody Sales Share by Application (2011-2016)

Figure Sales Market Share of Radioactive Monoclonal Antibody by Application (2011-2016)

Figure Global Radioactive Monoclonal Antibody Sales Growth Rate by Application (2011-2016)

Figure USA Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

Figure USA Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

Figure USA Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

Table USA Radioactive Monoclonal Antibody Sales by Manufacturers (2011-2016)

Table USA Radioactive Monoclonal Antibody Market Share by Manufacturers (2011-2016)

Table USA Radioactive Monoclonal Antibody Sales by Type (2011-2016)

Table USA Radioactive Monoclonal Antibody Market Share by Type (2011-2016)

Table USA Radioactive Monoclonal Antibody Sales by Application (2011-2016)

Table USA Radioactive Monoclonal Antibody Market Share by Application (2011-2016)

Figure China Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

Figure China Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

Figure China Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

Table China Radioactive Monoclonal Antibody Sales by Manufacturers (2011-2016)

Table China Radioactive Monoclonal Antibody Market Share by Manufacturers (2011-2016)

Table China Radioactive Monoclonal Antibody Sales by Type (2011-2016)

Table China Radioactive Monoclonal Antibody Market Share by Type (2011-2016)

Table China Radioactive Monoclonal Antibody Sales by Application (2011-2016)

Table China Radioactive Monoclonal Antibody Market Share by Application (2011-2016)

Figure Europe Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

Figure Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

Figure Europe Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

Table Europe Radioactive Monoclonal Antibody Sales by Manufacturers (2011-2016)

Table Europe Radioactive Monoclonal Antibody Market Share by Manufacturers (2011-2016)

Table Europe Radioactive Monoclonal Antibody Sales by Type (2011-2016)

Table Europe Radioactive Monoclonal Antibody Market Share by Type (2011-2016)

Table Europe Radioactive Monoclonal Antibody Sales by Application (2011-2016)

Table Europe Radioactive Monoclonal Antibody Market Share by Application (2011-2016)

Figure Japan Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

Figure Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

Figure Japan Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

Table Japan Radioactive Monoclonal Antibody Sales by Manufacturers (2011-2016)

Table Japan Radioactive Monoclonal Antibody Market Share by Manufacturers (2011-2016)

Table Japan Radioactive Monoclonal Antibody Sales by Type (2011-2016)

Table Japan Radioactive Monoclonal Antibody Market Share by Type (2011-2016)

Table Japan Radioactive Monoclonal Antibody Sales by Application (2011-2016)

Table Japan Radioactive Monoclonal Antibody Market Share by Application (2011-2016)

Figure India Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

Figure India Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

Figure India Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

Table India Radioactive Monoclonal Antibody Sales by Manufacturers (2011-2016)

Table India Radioactive Monoclonal Antibody Market Share by Manufacturers (2011-2016)

Table India Radioactive Monoclonal Antibody Sales by Type (2011-2016)

Table India Radioactive Monoclonal Antibody Market Share by Type (2011-2016)

Table India Radioactive Monoclonal Antibody Sales by Application (2011-2016)

Table India Radioactive Monoclonal Antibody Market Share by Application (2011-2016)

Figure Southeast Asia Radioactive Monoclonal Antibody Sales and Growth Rate (2011-2016)

Figure Southeast Asia Radioactive Monoclonal Antibody Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Radioactive Monoclonal Antibody Sales Price Trend (2011-2016)

Table Southeast Asia Radioactive Monoclonal Antibody Sales by Manufacturers (2011-2016)

Table Southeast Asia Radioactive Monoclonal Antibody Market Share by Manufacturers (2011-2016)

Table Southeast Asia Radioactive Monoclonal Antibody Sales by Type (2011-2016)

Table Southeast Asia Radioactive Monoclonal Antibody Market Share by Type (2011-2016)

Table Southeast Asia Radioactive Monoclonal Antibody Sales by Application (2011-2016)

Table Southeast Asia Radioactive Monoclonal Antibody Market Share by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information List

Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information List

Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information List

Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information List

Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information List

Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information List

Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information List

Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information List

Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information List

Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information List

Table ALZA Corporation (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Amgen Inc. (USA) Basic Information List

Table Amgen Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table AstraZeneca PLC (UK) Basic Information List

Table AstraZeneca PLC (UK) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca PLC (UK) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Medimmune, LLC (USA) Basic Information List

Table Medimmune, LLC (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Medimmune, LLC (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Bristol-Myers Squibb Company (USA) Basic Information List

Table Bristol-Myers Squibb Company (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Company (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Cell Genesys Inc. (USA) Basic Information List

Table Cell Genesys Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cell Genesys Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Dendreon Corporation (USA) Basic Information List

Table Dendreon Corporation (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Dendreon Corporation (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table EUSA Pharma, (USA) Inc. (USA) Basic Information List

Table EUSA Pharma, (USA) Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure EUSA Pharma, (USA) Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffmann-La Roche Ltd. (Switzerland) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List

Table Progenics Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Progenics Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Sanofi-Aventis SA (France) Basic Information List

Table Sanofi-Aventis SA (France) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi-Aventis SA (France) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List

Table Spectrum Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Spectrum Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Takeda Pharmaceutical Company Limited (Japan) Radioactive Monoclonal Antibody Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Radioactive Monoclonal Antibody

Figure Manufacturing Process Analysis of Radioactive Monoclonal Antibody

Figure Radioactive Monoclonal Antibody Industrial Chain Analysis

Table Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015

Table Major Buyers of Radioactive Monoclonal Antibody

Table Distributors/Traders List

Figure Global Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2016-2021)

Figure Global Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2016-2021)

Table Global Radioactive Monoclonal Antibody Sales Forecast by Regions (2016-2021)

Table Global Radioactive Monoclonal Antibody Sales Forecast by Type (2016-2021)

Table Global Radioactive Monoclonal Antibody Sales Forecast by Application (2016-2021)